Pharma-Bio Serv (PBSV) Invested Capital (2020 - 2021)

Pharma-Bio Serv (PBSV) posted Invested Capital of $1.3 million for Q2 2021, little changed on a QoQ basis from $1.3 million in Q1 2021, and up 100.0% year-over-year from $643900.0 in Q2 2020.

Pharma-Bio Serv (PBSV) Invested Capital (2020 - 2021) Analysis & Trends

Pharma-Bio Serv's Invested Capital history runs 2 years deep, the most recent figure standing at $1.3 million for Q2 2021.

  • Quarterly Invested Capital rose 100.0% year-over-year to $1.3 million in Q2 2021, while the trailing twelve-month figure through Jan 2022 was $1.3 million (down 56.56% YoY) and the FY2020 annual result came in at $67079.0, changed N/A from the prior year.
  • Invested Capital was $1.3 million for Q2 2021 at Pharma-Bio Serv, roughly flat from $1.3 million in the prior quarter.
  • Across five years, Invested Capital topped out at $1.3 million in Q1 2021 and bottomed at $67079.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Veeva Systems 31.92 Bn 24.61 Bn 662.02 Mn -
2 BrightSpring Health Services 14.59 Bn 13.69 Bn 482.22 Mn 52.96 Mn
3 Healthequity 8.31 Bn 8.04 Bn 256.31 Mn -
4 Hinge Health 5.97 Bn 5.65 Bn 154.23 Mn -
5 10x Genomics 5.82 Bn 5.28 Bn 106.18 Mn -
6 MiniMed 4.50 Bn 4.20 Bn 480.00 Mn -
7 Waystar Holding 4.49 Bn 4.43 Bn 216.84 Mn 14.19 Mn
8 Doximity 3.98 Bn 3.23 Bn 125.97 Mn -
9 Privia Health 3.18 Bn 2.76 Bn - -
10 Pharma-Bio Serv 13.28 Mn 4.81 Mn 902,041.00 -

Historic Data

Download Data
DateValue
Apr 30, 2021 1.29 Mn
Jan 31, 2021 1.29 Mn
Oct 31, 2020 67,079.00
Jul 31, 2020 965,850.00
Apr 30, 2020 643,900.00